UNSPSC 51112803: Ospemifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C24H23ClO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B0P231ILBK, chemically known as 2-(p-((z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol but more generally known as ospemifene, which bears US NIH Compound Identifier 3036505. European Medicines Agency schedules Ospemifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33020.

UNSPSC 51112803 Ospemifene, a Commodity code, covers the procurement of ospemifene, a selective estrogen receptor modulator (SERM) used in the treatment of moderate to severe dyspareunia in postmenopausal women. State and local governments purchase ospemifene primarily through their Medicaid programs, correctional health systems, and public health clinics as part of pharmaceutical benefit management and inmate healthcare services. The drug is typically procured either through established state pharmaceutical contracts, group purchasing organizations (GPOs), or direct purchase agreements negotiated by health authorities responsible for formulary management and drug distribution across multiple facilities and service populations.

The source provides no recent state and local solicitation activity under this code. Without posted RFP, RFQ, IFB, or ITB opportunities from state procurement offices, county health departments, municipal clinics, school districts, correctional agencies, or transit authorities, geographic concentration and issuing-body patterns cannot be established from current market signals. Pharmaceutical commodity codes at this specificity often reflect catalog procurement against standing state contracts or GPO agreements rather than discrete competitive notices; however, the absence of visible opportunities in the recent posting record limits assessment of current market appetite or regional concentration.